Cancer stem cells: basic concepts and therapeutic implications

D Nassar, C Blanpain - Annual Review of Pathology …, 2016 - annualreviews.org
Different mechanisms contribute to intratumor heterogeneity, including genetic mutations,
the microenvironment, and the existence of subpopulations of cancer cells with increased …

Folylpoly-γ-glutamate synthetase: a key determinant of folate homeostasis and antifolate resistance in cancer

S Raz, M Stark, YG Assaraf - Drug Resistance Updates, 2016 - Elsevier
Mammalians are devoid of autonomous biosynthesis of folates and hence must obtain them
from the diet. Reduced folate cofactors are B9-vitamins which play a key role as donors of …

Deciphering molecular mechanisms underlying chemoresistance in relapsed AML patients: towards precision medicine overcoming drug resistance

M Levin, M Stark, Y Ofran, YG Assaraf - Cancer cell international, 2021 - Springer
Background Acute myeloid leukemia (AML) remains a devastating disease with a 5-year
survival rate of less than 30%. AML treatment has undergone significant changes in recent …

Surmounting Cytarabine-resistance in acute myeloblastic leukemia cells and specimens with a synergistic combination of hydroxyurea and azidothymidine

M Levin, M Stark, B Berman, YG Assaraf - Cell Death & Disease, 2019 - nature.com
Acute myeloid leukemia (AML) patients display dismal prognosis due to high prevalence of
refractory and relapsed disease resulting from chemoresistance. Treatment protocols …

Enhanced sensitivity to glucocorticoids in cytarabine-resistant AML

D Malani, A Murumägi, B Yadav, M Kontro, S Eldfors… - Leukemia, 2017 - nature.com
We sought to identify drugs that could counteract cytarabine resistance in acute myeloid
leukemia (AML) by generating eight resistant variants from MOLM-13 and SHI-1 AML cell …

Inhibition of inflammatory signaling in Pax5 mutant cells mitigates B-cell leukemogenesis

M Isidro-Hernández, A Mayado, A Casado-García… - Scientific reports, 2020 - nature.com
PAX5 is one of the most frequently mutated genes in B-cell acute lymphoblastic leukemia (B-
ALL), and children with inherited preleukemic PAX5 mutations are at a higher risk of …

The first Japanese biobank of patient‐derived pediatric acute lymphoblastic leukemia xenograft models

K Tanaka, I Kato, Y Dobashi, J Imai, T Mikami… - Cancer …, 2022 - Wiley Online Library
A lack of practical resources in Japan has limited preclinical discovery and testing of
therapies for pediatric relapsed and refractory acute lymphoblastic leukemia (ALL), which …

[HTML][HTML] Stability of patient-specific features of altered DNA replication timing in xenografts of primary human acute lymphoblastic leukemia

T Sasaki, JC Rivera-Mulia, D Vera, J Zimmerman… - Experimental …, 2017 - Elsevier
Highlights•DNA replication timing profiling methodology for cryopreserved acute lymphoid
leukemia samples and patient-derived xenografts has been established.•Replication timing …

Stem cell hierarchy and clonal evolution in acute lymphoblastic leukemia

F Lang, B Wojcik, MA Rieger - Stem cells international, 2015 - Wiley Online Library
Cancer is characterized by a remarkable intertumoral, intratumoral, and cellular
heterogeneity that might be explained by the cancer stem cell (CSC) and/or the clonal …

The evolution of nucleosidic analogues: self-assembly of prodrugs into nanoparticles for cancer drug delivery

M Baroud, E Lepeltier, S Thepot, Y El-Makhour… - Nanoscale …, 2021 - pubs.rsc.org
Nucleoside and nucleotide analogs are essential tools in our limited arsenal in the fight
against cancer. However, these structures face severe drawbacks such as rapid plasma …